AWM Investment Company’s Eyegate Pharmaceuticals, Inc. Warrants EYEGW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-137,092
| Closed | -$6K | – | 98 |
|
|
2020
Q2 | $6K | Hold |
137,092
| – | – | ﹤0.01% | 87 |
|
|
2020
Q1 | $4K | Hold |
137,092
| – | – | ﹤0.01% | 86 |
|
|
2019
Q4 | $7K | Hold |
137,092
| – | – | ﹤0.01% | 86 |
|
|
2019
Q3 | $3K | Hold |
137,092
| – | – | ﹤0.01% | 88 |
|
|
2019
Q2 | $2K | Hold |
137,092
| – | – | ﹤0.01% | 92 |
|
|
2019
Q1 | $3K | Hold |
137,092
| – | – | ﹤0.01% | 85 |
|
|
2018
Q4 | $8K | Hold |
137,092
| – | – | ﹤0.01% | 84 |
|
|
2018
Q3 | $7K | Hold |
137,092
| – | – | ﹤0.01% | 89 |
|
|
2018
Q2 | $12K | Hold |
137,092
| – | – | ﹤0.01% | 91 |
|
|
2018
Q1 | $12K | Hold |
137,092
| – | – | ﹤0.01% | 91 |
|
|
2017
Q4 | $21K | Hold |
137,092
| – | – | ﹤0.01% | 93 |
|
|
2017
Q3 | $16K | Hold |
137,092
| – | – | ﹤0.01% | 89 |
|
|
2017
Q2 | $11K | Hold |
137,092
| – | – | ﹤0.01% | 92 |
|
|
2017
Q1 | $21K | Hold |
137,092
| – | – | ﹤0.01% | 96 |
|
|
2016
Q4 | $41K | Hold |
137,092
| – | – | 0.01% | 99 |
|
|
2016
Q3 | $48K | Hold |
137,092
| – | – | 0.01% | 98 |
|
|
2016
Q2 | $86K | Hold |
137,092
| – | – | 0.02% | 95 |
|
|
2016
Q1 | $103K | Hold |
137,092
| – | – | 0.02% | 92 |
|
|
2015
Q4 | $103K | Hold |
137,092
| – | – | 0.02% | 94 |
|
|
2015
Q3 | $140K | Buy |
+137,092
| New | +$169K | 0.03% | 115 |
|
AWM Investment Company's EYEGW Position: Q3 2020 in Review
AWM Investment Company sold out of Eyegate Pharmaceuticals, Inc. Warrants (EYEGW) in Q3 2020, closing a stake of 137,092 shares — an estimated $6K sold.
AWM Investment Company first reported a position in EYEGW in Q3 2015 and held it in 20 quarters. The position peaked at $140K in Q3 2015. 0 funds tracked by Wall St. Rank hold EYEGW as of Q3 2020.
- AWM Investment Company reported no remaining Eyegate Pharmaceuticals, Inc. Warrants position as of Q3 2020 after selling out during the quarter.
- AWM Investment Company sold 137,092 Eyegate Pharmaceuticals, Inc. Warrants shares in Q3 2020, an estimated $6K.
- AWM Investment Company first reported a position in Eyegate Pharmaceuticals, Inc. Warrants in Q3 2015 and held it in 20 quarters.
- AWM Investment Company's Eyegate Pharmaceuticals, Inc. Warrants position peaked at $140K in Q3 2015.
- 0 funds tracked by Wall St. Rank held Eyegate Pharmaceuticals, Inc. Warrants as of Q3 2020.
Based on AWM Investment Company's 13F filing for Q3 2020, filed 13 Nov 2020.